Evidence map›Paper›PMID 35857090›Full record

ArticleEuropean archives of psychiatry and clinical neuroscience2023

Eye movement indices as predictors of conversion to psychosis in individuals at clinical high risk.

Dan Zhang, Lihua Xu, Yuou Xie, Xiaochen Tang, Yegang Hu, Xu Liu, Guisen Wu, Zhenying Qian, Yingying Tang, Zhi Liu and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of psychiatry and clinical neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Dan ZhangShanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, People's Republic of China.
Lihua Xu *Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, People's Republic of China.
Yuou XieFirst Clinical Medical College of Nanjing Medical University, Nanjing, 211103, People's Republic of China.
Xiaochen TangShanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, People's Republic of China.
Yegang HuShanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, People's Republic of China.
Xu LiuShanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, People's Republic of China.
Guisen WuShanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, People's Republic of China.
Zhenying QianShanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, People's Republic of China.
Yingying TangShanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, People's Republic of China.
Zhi LiuShanghai Institute for Advanced Communication and Data Science, Shanghai University, Shanghai, 200444, People's Republic of China.
Tao ChenSenior Research Fellow, Labor and Worklife Program, Harvard University, Cambridge, MA, USA.
HaiChun LiuDepartment of Automation, Shanghai Jiao Tong University, Shanghai, 200240, People's Republic of China.
Tianhong ZhangShanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, People's Republic of China. zhang_tianhong@126.com.
Jijun WangShanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, People's Republic of China. jijunwang27@163.com.
Shanghai Mental Health Center · CNShanghai Jiao Tong University · CNCenter for Excellence in Brain Science and Intelligence Technology · CNNanjing Medical University · CNShanghai Industrial Technology Institute · CNShanghai University · CN

Funding

Clinical Research Center at Shanghai Jiao Tong University School of Medicine DLY201817Ministry of Science and Technology of China, National Key R&D Program of China 2016YFC1306800National Natural Science Foundation of China 62171269National Natural Science Foundation of China 81671329National Natural Science Foundation of China 81671332National Natural Science Foundation of China 81871050National Natural Science Foundation of China 81971251Science and Technology Commission of Shanghai Municipality (16JC1420200Science and Technology Commission of Shanghai Municipality 16ZR1430500Science and Technology Commission of Shanghai Municipality 19410710800Science and Technology Commission of Shanghai Municipality 19411969100Science and Technology Commission of Shanghai Municipality 19441907800Science and Technology Commission of Shanghai Municipality 20ZR1448600Science and Technology Commission of Shanghai Municipality 21S31903100Shanghai Jiao Tong University Foundation ZH2018QNB19Shanghai Jiao Tong University Foundation ZH2018ZDB03Shanghai Mental Health Center 2019-zd01Shanghai Municipal Health Commission 202040361Shanghai Municipal Science and Technology Major Project No. 2018SHZDZX01The Clinical Research Center at Shanghai Mental Health Center CRC2018YB01The Clinical Research Center at Shanghai Mental Health Center CRC2018ZD01The Clinical Research Center at Shanghai Mental Health Center CRC2018ZD04The Clinical Research Center at Shanghai Mental Health Center CRC2019ZD02"To the youth" Psychological class for middle school students 21DZ2300400
6 · The paper itself

Abstract

Eye movement abnormalities have been established as an "endophenotype" of schizophrenia. However, less is known about the possibility of these abnormalities as biomarkers for psychosis conversion among clinical high risk (CHR) populations. In the present study, 108 CHR individuals and 70 healthy controls (HC) underwent clinical assessments and eye-tracking tests, comprising fixation stability and free-viewing tasks. According to three-year follow-up outcomes, CHR participants were further stratified into CHR-converter (CHR-C; n = 21) and CHR-nonconverter (CHR-NC; n = 87) subgroups. Prediction models were constructed using Cox regression and logistic regression. The CHR-C group showed more saccades of the fixation stability test (no distractor) and a reduced saccade amplitude of the free-viewing test than HC. Moreover, the CHR-NC group exhibited excessive saccades and an increased saccade amplitude of the fixation stability test (no distractor; with distractor) compared with HC. Furthermore, two indices could effectively discriminate CHR-C from CHR-NC with an area under the receiver-operating characteristic (ROC) curve of 0.80, including the saccade number of the fixation stability test (no distractor) and the saccade amplitude of the free-viewing test. Combined with negative symptom scores of the Scale of Prodromal Symptoms, the area was 0.81. These findings support that eye movement alterations might emerge before the onset of clinically overt psychosis and could assist in predicting psychosis transition among CHR populations.

Indexed as

Psychotic DisordersSchizophreniaEye MovementsHumansProdromal SymptomsRisk FactorsSaccadesEye movementSchizophreniaTransitionUltra high risk

Identifiers

PMID35857090
OpenAlexW4285999529

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.